✕
Login
Register
Back to News
Myriad Genetics Affirms FY2026 Sales Guidance of $860.000M-$880.000M vs $864.099M Est
Benzinga Newsdesk
www.benzinga.com
Neutral 55.2%
Neg 0%
Neu 55.2%
Pos 0%
Comments
No comments yet. Be the first!
Join the discussion
Login to comment
Login to comment